The stock of Tiziana Life Sciences Ltd (TLSA) has gone up by 21.59% for the week, with a -6.14% drop in the past month and a 48.61% rise in the past quarter. The volatility ratio for the week is 11.98%, and the volatility levels for the past 30 days are 10.73% for TLSA. The simple moving average for the past 20 days is 4.93% for TLSA’s stock, with a 46.53% simple moving average for the past 200 days.
Is It Worth Investing in Tiziana Life Sciences Ltd (NASDAQ: TLSA) Right Now?
Moreover, the 36-month beta value for TLSA is 0.65. Analysts have varying opinions on the stock, with 1 analysts rating it as a “buy,” 0 as “overweight,” 0 as “hold,” and 0 as “sell.”
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The public float for TLSA is 121.18M and currently, short sellers hold a 0.10% of that float. On September 19, 2024, TLSA’s average trading volume was 252.75K shares.
TLSA) stock’s latest price update
The stock of Tiziana Life Sciences Ltd (NASDAQ: TLSA) has increased by 26.46 when compared to last closing price of 0.85.Despite this, the company has seen a gain of 21.59% in its stock price over the last five trading days. proactiveinvestors.com reported 2024-08-19 that Tiziana Life Sciences Ltd (NASDAQ:TLSA) has announced the appointment of Ivor Elrifi as its CEO, replacing acting CEO Gabriele Cerrone who will remain in his role as executive chairman of the board. The company highlighted that Elfiri previously served as the global head of the Patent Group at Cooley since 2014, and before that, he led the Patents division at Mintz Levin from 1999 to 2014.
Analysts’ Opinion of TLSA
Many brokerage firms have already submitted their reports for TLSA stocks, with B. Riley Securities repeating the rating for TLSA by listing it as a “Buy.” The predicted price for TLSA in the upcoming period, according to B. Riley Securities is $8 based on the research report published on December 22, 2020 of the previous year 2020.
TLSA Trading at 4.24% from the 50-Day Moving Average
After a stumble in the market that brought TLSA to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -38.51% of loss for the given period.
Volatility was left at 10.73%, however, over the last 30 days, the volatility rate increased by 11.98%, as shares sank -11.57% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +31.94% upper at present.
During the last 5 trading sessions, TLSA rose by +21.59%, which changed the moving average for the period of 200-days by +81.36% in comparison to the 20-day moving average, which settled at $1.0127. In addition, Tiziana Life Sciences Ltd saw 91.07% in overturn over a single year, with a tendency to cut further gains.
Stock Fundamentals for TLSA
The total capital return value is set at -2.58.
Based on Tiziana Life Sciences Ltd (TLSA), the company’s capital structure generated 0.04 points at debt to capital in total, while cash flow to debt ratio is standing at -63.55. The debt to equity ratio resting at 0.04. The interest coverage ratio of the stock is -2083.71.
Currently, EBITDA for the company is -15.34 million with net debt to EBITDA at 0.06.
Conclusion
To wrap up, the performance of Tiziana Life Sciences Ltd (TLSA) has been better in recent times. The stock has received a bullish of “buy” and “hold” ratings from analysts. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
